Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2005 1
2008 2
2009 7
2010 7
2011 5
2012 3
2013 4
2014 6
2015 7
2016 9
2017 3
2018 4
2019 2
2020 7
2021 5
2022 8
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Bacterial inclusion bodies are industrially exploitable amyloids.
de Marco A, Ferrer-Miralles N, Garcia-Fruitós E, Mitraki A, Peternel S, Rinas U, Trujillo-Roldán MA, Valdez-Cruz NA, Vázquez E, Villaverde A. de Marco A, et al. Among authors: ferrer miralles n. FEMS Microbiol Rev. 2019 Jan 1;43(1):53-72. doi: 10.1093/femsre/fuy038. FEMS Microbiol Rev. 2019. PMID: 30357330 Review.
Nanostructured antimicrobial peptides: The last push towards clinics.
Carratalá JV, Serna N, Villaverde A, Vázquez E, Ferrer-Miralles N. Carratalá JV, et al. Among authors: ferrer miralles n. Biotechnol Adv. 2020 Nov 15;44:107603. doi: 10.1016/j.biotechadv.2020.107603. Epub 2020 Jul 29. Biotechnol Adv. 2020. PMID: 32738381 Review.
Tools to cope with difficult-to-express proteins.
Saccardo P, Corchero JL, Ferrer-Miralles N. Saccardo P, et al. Among authors: ferrer miralles n. Appl Microbiol Biotechnol. 2016 May;100(10):4347-55. doi: 10.1007/s00253-016-7514-8. Epub 2016 Apr 14. Appl Microbiol Biotechnol. 2016. PMID: 27079572 Review.
Recombinant pharmaceuticals from microbial cells: a 2015 update.
Sanchez-Garcia L, Martín L, Mangues R, Ferrer-Miralles N, Vázquez E, Villaverde A. Sanchez-Garcia L, et al. Among authors: ferrer miralles n. Microb Cell Fact. 2016 Feb 9;15:33. doi: 10.1186/s12934-016-0437-3. Microb Cell Fact. 2016. PMID: 26861699 Free PMC article. Review.
Recombinant vaccines in 2022: a perspective from the cell factory.
de Pinho Favaro MT, Atienza-Garriga J, Martínez-Torró C, Parladé E, Vázquez E, Corchero JL, Ferrer-Miralles N, Villaverde A. de Pinho Favaro MT, et al. Among authors: ferrer miralles n. Microb Cell Fact. 2022 Oct 5;21(1):203. doi: 10.1186/s12934-022-01929-8. Microb Cell Fact. 2022. PMID: 36199085 Free PMC article. Review.
Recombinant protein materials for bioengineering and nanomedicine.
Corchero JL, Vázquez E, García-Fruitós E, Ferrer-Miralles N, Villaverde A. Corchero JL, et al. Among authors: ferrer miralles n. Nanomedicine (Lond). 2014 Dec;9(18):2817-28. doi: 10.2217/nnm.14.153. Nanomedicine (Lond). 2014. PMID: 25535685 Review.
Analytical approaches for assessing aggregation of protein biopharmaceuticals.
García-Fruitós E, Vazquez E, Gonzalez-Montalbán N, Ferrer-Miralles N, Villaverde A. García-Fruitós E, et al. Among authors: ferrer miralles n. Curr Pharm Biotechnol. 2011 Oct;12(10):1530-6. doi: 10.2174/138920111798357339. Curr Pharm Biotechnol. 2011. PMID: 21542795 Review.
85 results